Invo Bioscience Inc
General ticker "INVO" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $3.2M
Invo Bioscience Inc does not follow the US Stock Market performance with the rate: -34.0%.
Estimated limits based on current volatility of 4.7%: low 0.79$, high 0.87$
Factors to consider:
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [0.73$, 3.21$]
- 2024-12-30 to 2025-12-30 estimated range: [0.84$, 2.93$]
Financial Metrics affecting the INVO estimates:
- Negative: Non-GAAP EPS, $ of -9.03 <= 0.12
- Negative: Operating profit margin, % of -69.14 <= 1.30
- Negative: Operating cash flow per share per price, % of -67.24 <= 2.49
- Negative: negative Net income
- Negative: Industry earnings per price (median), % of -6.62 <= 1.37
- Negative: Industry operating cash flow per share per price (median), % of -5.31 <= 3.92
- Negative: 0 < Industry inventory ratio change (median), % of 0.19
- Negative: Industry operating profit margin (median), % of -26.46 <= 2.20
Short-term INVO quotes
Long-term INVO plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $4.16MM | $0.82MM | $3.02MM |
| Operating Expenses | $9.38MM | $11.45MM | $9.79MM |
| Operating Income | $-5.22MM | $-10.63MM | $-6.77MM |
| Non-Operating Income | $-1.43MM | $-0.26MM | $-1.24MM |
| Interest Expense | $1.27MM | $0.06MM | $0.93MM |
| R&D Expense | $0.22MM | $0.54MM | $0.17MM |
| Income(Loss) | $-6.65MM | $-10.89MM | $-8.01MM |
| Taxes | $0.00MM | $0.00MM | $0.03MM |
| Profit(Loss) | $-6.65MM | $-10.89MM | $-8.03MM |
| Stockholders Equity | $7.31MM | $-0.98MM | $0.89MM |
| Inventory | $0.29MM | $0.26MM | $0.26MM |
| Assets | $10.47MM | $4.10MM | $20.89MM |
| Operating Cash Flow | $-6.03MM | $-6.60MM | $-4.76MM |
| Investing Cash Flow | $-2.15MM | $-0.08MM | $-2.49MM |
| Financing Cash Flow | $3.77MM | $1.09MM | $7.39MM |
| Earnings Per Share* | $-12.52 | $-17.97 | $-5.13 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.